Ototoxicity
Healthcare Practice
Supportive Care and Guidelines
- 2020 CPG – Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline (The Lancet Child & Adolescent Health – Free access available with registration.)
- Endorsed by the Children’s Oncology Group (COG)
- 2019 Rapid Review – Interventions for cisplatin-induced hearing loss in children and adolescents with cancer: rapid review (The Lancet Child & Adolescent Health – not available as open access)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email: guidelines@pogo.ca
Mucositis
Healthcare Practice
Supportive Care and Guidelines
- 2021 CPG Update – Clinical practice guideline for the prevention of oral and oro-pharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients (open access at European Journal of Cancer)
- Endorsed by the Children’s Oncology Group (COG)
- Archived 2015 CPG – Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation (open access at BMJ Supportive and Palliative Care)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email: guidelines@pogo.ca
Fever and Neutropenia
Healthcare Practice
Supportive Care and Guidelines
- 2023 CPG Update – Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update (open access at Journal of Clinical Oncology)
- Endorsed by the Children’s Oncology Group (COG) and the Multinational Association of Supportive Care in Cancer (MASCC)
- Archived 2017 CPG – Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update (open access at Journal of Clinical Oncology)
- Archived 2012 CPG – Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem cell transplantation (open access at Journal of Clinical Oncology)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email: guidelines@pogo.ca
Fertility Preservation*
Fertility Preservation
Supportive Care and Guidelines
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
This supportive care CPG has been endorsed by POGO
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email: guidelines@pogo.ca
Fatigue
Healthcare Practice
Supportive Care and Guidelines
- 2023 CPG – Guideline for the management of fatigue in children and adolescents with cancer or pediatric hematopoietic cell transplant recipients: 2023 Update (open access at eClinicalMedicine)
- Endorsed by the Children’s Oncology Group (COG) and the Multinational Association of Supportive Care in Cancer (MASCC)
- Archived 2018 CPG – Management of fatigue in children and adolescents with cancer and in paediatric recipients of haemopoietic stem-cell transplants: a clinical practice guideline (The Lancet Child & Adolescent Health – free access available with registration)
- Read the accepted Word version here.
- Endorsed by the Children’s Oncology Group (COG)
- 2017 SR – Mind and body practices for fatigue reduction in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis (Critical Reviews in Oncology/Hematology – not available as open access)
- 2018 Meta-analysis – Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis (open access at Current Oncology)
- 2018 SR – Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of randomized trials (Critical Reviews in Oncology/Hematology – not available as open access)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email: guidelines@pogo.ca
Emetogenicity Classification
Healthcare Practice
Supportive Care and Guidelines
- 2019 CPG Update – Classification of the acute emetogenicity of chemotherapy in pediatric patients: a clinical practice guideline (open access at Pediatric Blood and Cancer)
- Endorsed by the Children’s Oncology Group (COG)
- Archived 2011 CPG – Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients (open access at Pediatric Blood and Cancer)
- Quick Summary
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email: guidelines@pogo.ca
Clostridium Difficile Infection
Healthcare Practice
Supportive Care and Guidelines
- 2024 CPG – Guideline for the management of clostridioides difficile infection in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2024 update (open access at eClinicalMedicine)
- Endorsed by the Children’s Oncology Group (COG) and the Multinational Association of Supportive Care in Cancer (MASCC)
- Archived 2018 CPG – Guideline for the management of clostridium difficile infection in children and adolescents with cancer and pediatric hematopoietic stem-cell transplantation recipients (open access at Journal of Clinical Oncology)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email: guidelines@pogo.ca
Chronic Pain*
Chronic Pain
Supportive Care and Guidelines
This supportive care CPG has been endorsed by POGO
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email: guidelines@pogo.ca
Chemotherapy-Induced Nausea and Vomiting
Healthcare Practice
Supportive Care and Guidelines
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email: guidelines@pogo.ca
Acute and Delayed CINV
Healthcare Practice
Supportive Care and Guidelines
- 2022 CPG – Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline (open access at Pediatric Blood and Cancer)
- Endorsed by the Children’s Oncology Group (COG) and the Multinational Association of Supportive Care in Cancer (MASCC)
- Archived 2017 CPG – Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update (open access at Pediatric Blood and Cancer)
- Quick Summary (PDF)
- Endorsed by the Children’s Oncology Group (COG)
- Archived 2013 CPG – Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients (open access at Pediatric Blood and Cancer)
- Quick Summary (PDF)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email: guidelines@pogo.ca
